期刊文献+

电喷雾离子阱质谱法研究射干苷与血浆蛋白的非共价结合 被引量:3

Non-covalent binding between tectoridin and plasma proteins by electrospray ion trap mass spectrometry
下载PDF
导出
摘要 目的研究射干苷与血浆蛋白的非共价结合特性。方法采用电喷雾离子阱质谱分别测定射干苷、人血清白蛋白、α1-酸性糖蛋白及其所形成复合物的相对分子质量。通过结合前后的相对分子质量的变化计算复合物最大化学计量比;通过Scatchard方程拟合计算复合物结合常数K;根据反应温度和热力学常数△H、△S推测复合物间的作用力类型。结果射干苷与人血清白蛋白、α1-酸性糖蛋白形成的非共价复合物K分别为1.914×104mol/L和5.893×104mol/L,结合倍数分别为7.8和3.3复合物间的作用力主要为静电引力。结论电喷雾离子阱质谱法应用于射干苷与蛋白质结合的研究具有灵敏度高、特异性强、分析迅速等优点。 Objective To study the non-covalent binding between the tectoridin (TE) and plasma proteins. Methods The molecular weights of TE, human serum albumin (HSA), α1-acid glycoprotein (AAG) and the protein-drug complexes were measured by the electrospray ion trap mass spectrometry (ESI-MS). The maximum stoichiometric ratios were obtained according to the molecular weight change of the complexes before and after binding reaction. The binding constants (K) of the complexes were calculated by the Scatchard equation. The main sorts of binding force of the complexes were deduced according to the relationship between the reaction temperature and the thermodynamic parameters (△H and △S). Results The K of the complexes were 1. 914 ×10^4 mol/L for TE-HSA and 5. 893 ×10^4 mol/L for TEAAG, and the number of binding sites were 7.8 and 3.3, respectively. The main sorts of binding force between TE-HSA or TE-AAG were static-electricity gravitation. Conclusion ESI-MS is a good method for studying of the TE-protein non-covalent binding with some advantages in sensitivity, high-speed, and accuracy.
出处 《中草药》 CAS CSCD 北大核心 2007年第10期1473-1476,共4页 Chinese Traditional and Herbal Drugs
基金 湖北省杰出青年基金资助项目(2002AC004) 中药生物技术省重点实验室开放基金项目(040106)
关键词 射干苷 人血清白蛋白 Α1-酸性糖蛋白 电喷雾离子阱质谱 tectoridin (TE) human serum albumin (HSA) α1-acid glycoprotein (AAG) electrospray ion trap mass spectrometry
  • 相关文献

参考文献10

  • 1郭宾,李川.药物与血浆蛋白结合的药理学基础及其研究进展[J].中国临床药理学与治疗学,2005,10(3):241-253. 被引量:53
  • 2Frank S,Carol V R.Characterising electrosprayed biomolecules using tandem-MS the non-covalent GroEL chaperonin assembly[J].Int J Mass Spectr,2004,236:25-32.
  • 3Griffey R H,Sannes-Lowery K A,Drader J J,et al.Characterization of low-affinity complexes between RNA and small molecules using electrospray ionization mass spectrometry[J].J Am Chem Soc,2000,122:9933-9938.
  • 4Wei H G,Gregory G P,Ingrid F,et al.A mass spectrometric study of noncovalent gas phase interaction of staphylococcal nucleases with 5' -nucleoside phosphate inhibitors[J].Int J Mass Spectr,2003,222:397-412.
  • 5Michael P,Udo H V,Paul K.Features of the ESI mechanism that affect the observation of multiply charged noncovalent protein complexes and the determination of the association constant by the Titration method[J].Biol Mass Spectr,2004,15:1424-1434.
  • 6Jurg M D,Gregor M,Silke W,et al.Mass spectrometric determination of association constants of adenylate kinase with two noncovalent inhibitors Renato[J].J Am Soc Mass Spectr,2003,14:442-448.
  • 7Sarkar B.Metal Ions In Biological System[M].New York;Marcel Dekker,1991.
  • 8汪海林,邹汉法,张玉奎.微透析-液相色谱法研究药物与蛋白竞争结合[J].中国科学(B辑),1998,28(1):71-77. 被引量:17
  • 9LIANG W Q.Biopharmaceutics and Pharmacokinetics (生物药剂学与药物动力学)[M].Beijing:People's Medical Press,2003:94-95.
  • 10Scatchard G,Scheinberg I H.Armstrong S H.Physical chemistry of protein solutions.The combination of human serum albumin with chloride ion[J].J Am Chem Soc,1950,72:535~540.

二级参考文献93

  • 1Kremer JM, Wilting J, Janssen LH. Drug binding to human alpha-1-acid glycoprotein in health and disease[J]. Pharmacol Rev, 1988; 40:1-47
  • 2Reidenberg MM, Erill S. Drug-protein binding[M]. New York: Praeger Publishers, 1986
  • 3Meyer MC, Guttman DE. The binding of drugs by plasma proteins[J]. J Pharm Sci, 1968; 57: 895-918
  • 4Oravcova J, Bohs B, Lindner W. Drug-protein binding sites.New trends in analytical and experimental methodology[ J]. J Chromatogr B Biomed Appl, 1996; 677:1 - 28
  • 5Wright JD, Boudinot FD, Ujhelyi MR. Measurement and analysis of unbound drug concentrations [J]. Clin Pharmacokinet,1996; 30: 445- 62
  • 6Heringa MB, Pastor D, Algra J, Vaes WH, Hermens JL. Negligible depletion solid-phase microextraction with radiolabeled analytes to study free concentrations and protein binding: an example with [3H]estradiol[J]. Anal Chem, 2002; 74: 5993-7
  • 7Dockal M, Carter DC, Ruker F. Conformational transitions of the three recombinant domains of human serum albumin depending on pH[J]. J Biol Chem, 2000; 275:3042-50
  • 8Dockal M, Carter DC, Ruker F. The three recombinant domains of human serum albumin. Structural characterization and ligand binding properties[J]. J Biol Chem, 1999; 274:29303- 10
  • 9Colmenarejo G. In silico prediction of drug-binding strengths to human serum albumin [J]. Med Res Rev, 2003; 23: 275 -301
  • 10Sudlow G, Birkett DJ, Wade DN. The characterization of two specific drug binding sites on human serum albumin [J]. Mol Pharmacol, 1975; 11:824-32

共引文献68

同被引文献36

引证文献3

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部